New Zealand markets open in 8 hours 30 minutes

Hualan Biological Vaccine Inc. (301207.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
18.19+0.72 (+4.12%)
At close: 03:04PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 10.50B
Enterprise value 7.78B
Trailing P/E 13.90
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.96
Price/book (mrq)1.66
Enterprise value/revenue 3.38
Enterprise value/EBITDA 8.19

Trading information

Stock price history

Beta (5Y monthly) 0.74
52-week change 3-45.41%
S&P500 52-week change 324.96%
52-week high 336.09
52-week low 317.01
50-day moving average 320.58
200-day moving average 325.96

Share statistics

Avg vol (3-month) 32.71M
Avg vol (10-day) 32.1M
Shares outstanding 5601.03M
Implied shares outstanding 6608.68M
Float 882.53M
% held by insiders 185.98%
% held by institutions 13.03%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.6
Forward annual dividend yield 43.43%
Trailing annual dividend rate 30.60
Trailing annual dividend yield 33.43%
5-year average dividend yield 4N/A
Payout ratio 423.86%
Dividend date 3N/A
Ex-dividend date 414 Jun 2024
Last split factor 21.5:1
Last split date 307 Jun 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 34.98%
Operating margin (ttm)42.59%

Management effectiveness

Return on assets (ttm)6.86%
Return on equity (ttm)13.52%

Income statement

Revenue (ttm)2.3B
Revenue per share (ttm)3.83
Quarterly revenue growth (yoy)-76.40%
Gross profit (ttm)N/A
EBITDA 959.69M
Net income avi to common (ttm)804.59M
Diluted EPS (ttm)1.26
Quarterly earnings growth (yoy)-58.90%

Balance sheet

Total cash (mrq)3.37B
Total cash per share (mrq)5.61
Total debt (mrq)300M
Total debt/equity (mrq)4.76%
Current ratio (mrq)3.65
Book value per share (mrq)10.51

Cash flow statement

Operating cash flow (ttm)791.91M
Levered free cash flow (ttm)481.61M